Acumen Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Acumen Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ABOS.
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical...
Can you invest in Acumen Pharmaceuticals, Inc.?
Yes. Acumen Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ABOS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Acumen Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.